AU2001256334A1 - Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs - Google Patents

Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs

Info

Publication number
AU2001256334A1
AU2001256334A1 AU2001256334A AU5633401A AU2001256334A1 AU 2001256334 A1 AU2001256334 A1 AU 2001256334A1 AU 2001256334 A AU2001256334 A AU 2001256334A AU 5633401 A AU5633401 A AU 5633401A AU 2001256334 A1 AU2001256334 A1 AU 2001256334A1
Authority
AU
Australia
Prior art keywords
omega
acids
clinical signs
conjugated linoleic
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256334A
Inventor
Klaus Sommermeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Deutschland GmbH
Original Assignee
Fresenius Kabi Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7640945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001256334(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi Deutschland GmbH filed Critical Fresenius Kabi Deutschland GmbH
Publication of AU2001256334A1 publication Critical patent/AU2001256334A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention relates to the combined use of omega -3-fatty acids and/or their derivatives and of conjugated linoleic acids (CLA) and/or derivatives thereof for producing a preparation for use against clinical signs with pronounced immunological components.
AU2001256334A 2000-05-05 2001-05-03 Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs Abandoned AU2001256334A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10022001 2000-05-05
DE10022001 2000-05-05
PCT/EP2001/005011 WO2001085161A1 (en) 2000-05-05 2001-05-03 Combination preparation consisting of φ-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs

Publications (1)

Publication Number Publication Date
AU2001256334A1 true AU2001256334A1 (en) 2001-11-20

Family

ID=7640945

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256334A Abandoned AU2001256334A1 (en) 2000-05-05 2001-05-03 Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs

Country Status (7)

Country Link
EP (1) EP1296669B1 (en)
AT (1) ATE312604T1 (en)
AU (1) AU2001256334A1 (en)
DE (1) DE50108392D1 (en)
DK (1) DK1296669T3 (en)
ES (1) ES2250397T3 (en)
WO (1) WO2001085161A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10329839A1 (en) * 2003-06-04 2005-01-05 Hogl, Peter Use of artificial nutrition solutions to treat skin diseases, especially psoriasis, neurodermatitis, acne, dermatoses or eczema
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021912A1 (en) * 1992-04-28 1993-11-11 Fresenius Ag Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases
DE4432633C2 (en) * 1994-09-14 1997-07-31 Singer Peter Dr Med Priv Doz Pharmaceutical preparation for the local treatment of psoriasis, atopic dermatitis and eczema
GB9621630D0 (en) * 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
EP1005277A4 (en) * 1997-08-18 2001-08-29 Univ South Dakota Dairy products with enhanced cla content

Also Published As

Publication number Publication date
WO2001085161A1 (en) 2001-11-15
ES2250397T3 (en) 2006-04-16
DK1296669T3 (en) 2006-04-18
ATE312604T1 (en) 2005-12-15
EP1296669B1 (en) 2005-12-14
DE50108392D1 (en) 2006-01-19
EP1296669A1 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
AU658619B2 (en) Benzopyranones, methods of manufacture and use thereof
BG103335A (en) Application of fumaric acid derivatives
DE69727138D1 (en) DIETETIC BABY FOOD WITH CONJUGATED LINOLIC ACIDS
WO2003011873A8 (en) Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
NO20005565D0 (en) Preparations with conjugated linoleic acid enriched with isomers
AU1685499A (en) Polypeptide, their production and use
WO2000067801A3 (en) Prodrugs of chemotherapeutic agents with oxaalkanoic acids
AU4871797A (en) Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it
EP0895777A3 (en) Compositions based on peroxyacids
AU1277397A (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
YU47100A (en) Novel dihydroxahexanoic acid derivatives
HU9602740D0 (en) Halofanthine free base for the treatment of malaria and compositions
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2001265186A1 (en) Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
AU7384094A (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
HUP0202729A2 (en) Compositions for parenteral use of estramustine phosphate and amino acids
AU2634101A (en) Therapeutic preparations of highly unsaturated fatty acids
AU2001256334A1 (en) Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
WO2002087535A3 (en) Use of esterquats
UA42797C2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives and isoindole derivatives for preparation thereof
AU3893493A (en) Micro-organisms, preparation method therefor and uses thereof
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
WO2001083550A3 (en) Gpr22 modulators as appetite-control agents
AU2001225523A1 (en) Novel arylpropionaldehyde derivatives and production and use of the same